Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | ABL1 | P00519 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | G6PD | P11413 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23905325 | 0.89 | MAPT (0.33) | MAPTSMN1; SMN2KMT2AABL1 | |
| SCHEMBL23904783 | 0.86 | MAPT (0.34) | MAPTSMN1; SMN2KMT2AALDH1A1GAA | |
| SCHEMBL23905730 | 0.84 | — | — | |
| SCHEMBL23905327 | 0.83 | CFTR (0.34) | MAPTSMN1; SMN2KMT2AALDH1A1GAA | |
| SCHEMBL23905381 | 0.81 | CFTR (0.33) | MAPTSMN1; SMN2KMT2A | |
| SCHEMBL23904856 | 0.81 | PTPN1 (0.31) | ABL1ALDH1A1 | |
| SCHEMBL23904873 | 0.77 | — | — | |
| SCHEMBL23904760 | 0.76 | ABL1 (0.31) | ABL1ALDH1A1 | |
| SCHEMBL23905383 | 0.75 | MEN1 (0.33) | MAPTSMN1; SMN2KMT2AALDH1A1GAA | |
| SCHEMBL26525880 | 0.74 | GRM2 (0.34) | MAPTSMN1; SMN2KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021198981-A1 | ANTIVIRAL COMPOUNDS AND USES THEREOF | Janssen Biopharma, Inc. (US) | 2021-10-07 | — | — | WO | disclosed |